Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: Heparin

Neutral effect of P2Y12 inhibitors in non-critical COVID-19 hospitalisations

Presented By
Prof. Jeffrey Berger, New York University Langone, USA
Trial
ACTIV-4A
Conference
AHA 2021

14 January, 2022 16:30

COVID-19: Thromboembolic risk reduction with therapeutic heparin dosing

Presented By
Prof. Alex Spyropoulos, Northwell Health, USA
Trial
Phase 3, HEP-COVID
Conference
ESC 2021

26 October, 2021 16:34
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy